Product Information

VERAPAMIL 80 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0673 per EA under NDC 62135074490. Its NADAC has been published 154 times since Dec 13, 2023.

FDA first approved this application on Apr 5, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL 80 MG TABLET

VERAPAMIL HYDROCHLORIDE
$0.0673per EA

Strength

80 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135074490

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA071881

FDA Approved

4/5/1988

TE Code

AB

On Market Since

1/7/2011

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL 80 MG TABLET has been published 154 times since Dec 13, 2023, and over the history we have for it it has risen 20.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0673 per EA
All-time high$0.0861 (Jul 15, 2026)
All-time low$0.0466 (Nov 20, 2024)
52-week high$0.0861
52-week low$0.0630
Median price$0.0584
Average price$0.0616
Largest weekly change-18.2% (Nov 20, 2024)
Weeks tracked154
Tracking sinceDec 13, 2023

Price History

1W

-6.0%

1M

-8.1%

3M

-5.3%

6M

-16.1%

1Y

-3.4%

3Y

N/A

5Y

N/A

All

+20.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VERAPAMIL 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 80 MG TABLET, manufactured by Chartwell RX LLC, is $0.0673 per EA (NDC 62135074490), effective Nov 18, 2026.

How has the price of VERAPAMIL 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for VERAPAMIL 80 MG TABLET has risen 20.2%. It has been tracked across 154 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for VERAPAMIL 80 MG TABLET?

Since Dec 13, 2023, the NADAC for VERAPAMIL 80 MG TABLET has ranged from a low of $0.0466 (Nov 20, 2024) to a high of $0.0861 (Jul 15, 2026), with a median of $0.0584 per EA.

Are there cheaper alternatives to VERAPAMIL 80 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL 80 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures VERAPAMIL 80 MG TABLET?

VERAPAMIL 80 MG TABLET (NDC 62135074490) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.